Close Menu

NEW YORK – Kephera Diagnostics said on Monday that it has been awarded a $600,000 National Institutes of Health grant to develop a point-of-care test for neurocysticercosis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.